000 01350 a2200385 4500
005 20250511151726.0
264 0 _c19761223
008 197612s 0 0 eng d
022 _a0028-4793
024 7 _a10.1056/NEJM197611112952005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBremner, W J
245 0 0 _aThe prospects for new, reversible male contraceptives.
_h[electronic resource]
260 _bThe New England journal of medicine
_cNov 1976
300 _a1111-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBehavior
_xdrug effects
650 0 4 _aContraceptive Agents, Male
_xadministration & dosage
650 0 4 _aEpididymis
_xdrug effects
650 0 4 _aFemale
650 0 4 _aFollicle Stimulating Hormone
_xantagonists & inhibitors
650 0 4 _aForecasting
650 0 4 _aHumans
650 0 4 _aLibido
_xdrug effects
650 0 4 _aLuteinizing Hormone
_xantagonists & inhibitors
650 0 4 _aMale
650 0 4 _aPregnancy
650 0 4 _aResearch
650 0 4 _aSperm Maturation
_xdrug effects
650 0 4 _aSpermatogenesis
_xdrug effects
650 0 4 _aTestis
_xdrug effects
700 1 _ade Kretser, D M
773 0 _tThe New England journal of medicine
_gvol. 295
_gno. 20
_gp. 1111-7
856 4 0 _uhttps://doi.org/10.1056/NEJM197611112952005
_zAvailable from publisher's website
999 _c801364
_d801364